A proteomics-based methodology to investigate the protein corona effect for targeted drug delivery

被引：16

作者：

Pozzi, D. ^{[1
]}

Caracciolo, G. ^{[1
]}

Capriotti, A. L. ^{[2
]}

Cavaliere, C. ^{[2
]}

Piovesana, S. ^{[2
]}

Colapicchioni, V. ^{[3
]}

Palchetti, S. ^{[4
]}

Riccioli, A. ^{[4
]}

Lagana, A. ^{[2
]}

机构：

[1] Univ Roma La Sapienza, Dept Mol Med, I-00161 Rome, Italy

[2] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy

[3] Ist Italiano Tecnol, Ctr Life Nanosci Sapienza, I-00161 Rome, Italy

[4] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthopaed, Sect Histol & Med Embryol, I-00161 Rome, Italy

来源：

MOLECULAR BIOSYSTEMS | 2014年 / 10卷 / 11期

关键词：

NANOPARTICLE UPTAKE; LIPOSOMES; MEMBRANE; SURFACE;

D O I：

10.1039/c4mb00292j

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Here we introduce a proteomics methodology based on nanoliquid-chromatography tandem mass spectrometry (nanoLC/MS-MS) to investigate the "protein corona effect for targeted drug delivery", an innovative strategy, which exploits the "protein corona" that forms around nanoparticles in a physiological environment to target cells.

引用

页码：2815 / 2819

页数：5

共 50 条

[21] Methodology for characterization of platinum-based drug's targeted delivery nanosystems
Zajda, J.
Wroblewska, A.
Ruzik, L.
Matczuk, M.
JOURNAL OF CONTROLLED RELEASE, 2021, 335 : 178 - 190
[22] Targeted Proteomics-Based Quantitative Protein Atlas of Pannexin and Connexin Subtypes in Mouse and Human Tissues and Cancer Cell Lines
Tachikawa, Masanori
Kaneko, Yosuke
Ohtsuki, Sumio
Uchida, Yasuo
Watanabe, Michitoshi
Ohtsuka, Hideo
Terasaki, Tetsuya
JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 109 (02) : 1161 - 1168
[23] Dual-Targeted Drug Delivery to Myeloid Leukemia Cells via Complement- and Transferrin-Based Protein Corona
Wu, Wen
Li, Yuanyuan
Liu, Qihui
Liu, Tao
Zhao, Yanan
Shao, Hui
Ren, Ping
Tang, Yueyang
Feng, Jiayi
Wang, Yihan
Sun, Guodong
Liu, Haiyan
Bai, Yuansong
Chen, Fangfang
NANO LETTERS, 2024, 25 (01) : 147 - 156
[24] Identification of a membrane protein responsible for the sorting of serglycin: a proteomics-based study
Srivastava, S.
Lemansky, P.
Gupta, D. K.
Hasilik, A.
FEBS JOURNAL, 2006, 273 : 369 - 370
[25] Strategy for Avoiding Protein Corona Inhibition of Targeted Drug Delivery by Linking Recombinant Affibody Scaffold to Magnetosomes
Ma, Shijiao
Gu, Chenchen
Xu, Junjie
He, Jinxin
Li, Shuli
Zheng, Haolan
Pang, Bo
Wen, Ying
Fang, Qiaojun
Liu, Weiquan
Tian, Jiesheng
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2022, 17 : 665 - 680
[26] The protein corona and its effects on nanoparticle-based drug delivery systems
Li, Hanmei
Wang, Yao
Tang, Qi
Yin, Dan
Tang, Chuane
He, En
Zou, Liang
Peng, Qiang
ACTA BIOMATERIALIA, 2021, 129 : 57 - 72
[27] Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer
Palchetti, Sara
Caputo, Damiano
Digiacomo, Luca
Capriotti, Anna Laura
Coppola, Roberto
Pozzi, Daniela
Caracciolo, Giulio
PHARMACEUTICS, 2019, 11 (01):
[28] Serum biomarkers in patients with drug-resistant epilepsy: a proteomics-based analysis
Ma, Mian
Cheng, Ying
Hou, Xiaoxia
Li, Zhisen
Wang, Meixia
Ma, Bodun
Cheng, Qingzhang
Ding, Zhiliang
Feng, Hongxuan
FRONTIERS IN NEUROLOGY, 2024, 15
[29] Targeted LC-MS/MS Proteomics-Based Strategy To Characterize in Vitro Models Used in Drug Metabolism and Transport Studies
Xu, Meijuan
Saxena, Neha
Vrana, Marc
Zhang, Haeyoung
Kumar, Vineet
Billington, Sarah
Khojasteh, Cyrus
Heyward, Scott
Unadkat, Jashvant D.
Prasad, Bhagwat
ANALYTICAL CHEMISTRY, 2018, 90 (20) : 11873 - 11882
[30] PROTEIN GENERATOR ENABLES PROTEOMICS-BASED SUBTYPING OF IDH MUTANT ASTROCYTOMA
Wang, Hui
Tang, Jihong
Liu, Xing
Fan, Wenhua
Jiang, Tao
Wang, Jiguang
NEURO-ONCOLOGY, 2024, 26

← 1 2 3 4 5 →